Literature DB >> 19372443

Decompressive hemicraniectomy in cerebral sinus thrombosis: consecutive case series and review of the literature.

Jonathan M Coutinho, Charles B L M Majoie, Bert A Coert, Jan Stam.   

Abstract

BACKGROUND AND
PURPOSE: Thirteen percent of patients with cerebral venous and sinus thrombosis (CVST) has a poor clinical outcome. In patients with a poor prognosis, endovascular thrombolysis can be considered, but this procedure does not appear to be beneficial in patients with impending transtentorial herniation because of large hemorrhagic venous infarcts. Therefore, halfway through 2006, we changed our policy to decompressive hemicraniectomy in these patients.
METHODS: Patients with CVST and impending herniation attributable to venous infarcts were eligible for surgical intervention. Since 2006 we consecutively treated 3 patients with decompressive hemicraniectomy. Two patients had an excellent outcome. The third patient, who had been comatose for at least 12 hours before surgery, died despite intervention.
CONCLUSIONS: Our data suggest that decompressive hemicraniectomy can be life-saving and can result in an excellent outcome in patients with severe CVST.

Entities:  

Mesh:

Year:  2009        PMID: 19372443     DOI: 10.1161/STROKEAHA.108.543421

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

1.  Acute neurological issues in pregnancy and the peripartum.

Authors:  Catherine M Hosley; Louise D McCullough
Journal:  Neurohospitalist       Date:  2011-04

Review 2.  Role, Effectiveness, and Outcome of Decompressive Craniectomy for Cerebral Venous and Dural Sinus Thrombosis (CVST): Is Surgery Really an Option?

Authors:  Mohamed Wael F Mohamed; Su Sandi Aung; Nakul Mereddy; Sruthi Priyavadhana Ramanan; Pousette Hamid
Journal:  Cureus       Date:  2020-12-17

3.  Safety and efficacy of the use of large bore intermediate suction catheters alone or in combination for the treatment of acute cerebral venous sinus thrombosis: A multicenter experience.

Authors:  Sudeepta Dandapat; Edgar A Samaniego; Viktor Szeder; Fazeel M Siddiqui; Gary R Duckwiler; Ume Kiddy; Waldo R Guerrero; Binbin Zheng; David Hasan; Colin Derdeyn; Santiago Ortega-Gutierrez
Journal:  Interv Neuroradiol       Date:  2019-07-31       Impact factor: 1.610

4.  Surgical treatment of space occupying edema and hemorrhage due to cerebral venous thrombosis during pregnancy.

Authors:  Markus Ebke; Kai-Uwe Jürgens; Bernd Tomandl; Ute Merten; Andreas Kastrup
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

5.  Rare presentation of iron deficiency anaemia with cerebral venous sinus thrombosis in a middle-aged woman.

Authors:  Amna Bibi; Chathuri Liyanapthirana; Sajjad Khan
Journal:  BMJ Case Rep       Date:  2019-01-17

6.  Decompressive surgery in malignant cerebral venous sinus thrombosis: what predicts its outcome?

Authors:  Rohan Mahale; Anish Mehta; Ravi Gopal Varma; Alangar S Hegde; Purushottam T Acharya; Rangasetty Srinivasa
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

7.  Will molecular optical imaging have clinically important roles in stroke management, and how?

Authors:  Dong Kun Lee; Matthias Nahrendorf; Dawid Schellingerhout; Dong-Eog Kim
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

8.  Sequential escalation of therapy in "malignant" cerebral venous and sinus thrombosis.

Authors:  Christian Dohmen; Norbert Galldiks; Walter Moeller-Hartmann; Gereon R Fink; Lars Timmermann
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

Review 9.  [Therapeutic options in malignant cerebral venous and sinus thrombosis].

Authors:  S Schönenberger; C Geisbüsch; S Nagel; W Hacke; J Bösel
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

10.  Severe Cerebral Venous and Sinus Thrombosis: Clinical Course, Imaging Correlates, and Prognosis.

Authors:  Christina M Kowoll; Julia Kaminski; Verena Weiß; Julian Bösel; Wenke Dietrich; Eric Jüttler; Julia Flechsenhar; Albrecht Guenther; Hagen B Huttner; Wolf-Dirk Niesen; Thomas Pfefferkorn; Ingo Schirotzek; Hauke Schneider; Thomas Liebig; Christian Dohmen
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.